Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct;30(11):6290-6292.
doi: 10.1245/s10434-023-13805-9. Epub 2023 Jul 2.

Staging of the Axilla After Neoadjuvant Chemotherapy: Which Technique is Better? The Endless Debate

Giacomo Montagna  1 , Mahmoud B El-Tamer  2
Affiliations
Editorial

Staging of the Axilla After Neoadjuvant Chemotherapy: Which Technique is Better? The Endless Debate

Giacomo Montagna et al. Ann Surg Oncol. 2023 Oct.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Petruolo O, Sevilimedu V, Montagna G, Le T, Morrow M, Barrio AV. How often does modern neoadjuvant chemotherapy downstage patients to breast-conserving surgery? Ann Surg Oncol. 2021;28:287–94. - DOI - PubMed
    1. Montagna G, Mamtani A, Knezevic A, Brogi E, Barrio AV, Morrow M. Selecting node-positive patients for axillary downstaging with neoadjuvant chemotherapy. Ann Surg Oncol. 2020;27:4515–22. - DOI - PubMed - PMC
    1. Weber WP, Davide Gentilini O, Morrow M, et al. Uncertainties and controversies in axillary management of patients with breast cancer. Cancer Treat Rev. 2023;117:102556. - DOI - PubMed
    1. Dubsky P, Pinker K, Cardoso F, et al. Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Lancet Oncol. 2021;22:e18-28. - DOI - PubMed
    1. von Minckwitz G, Huang CS, Mano MS, et al. Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med. 2019;380:617–28. - DOI

LinkOut - more resources